New Coronary Risk Score for Women
The model accurately predicted major adverse cardiovascular events in women who were categorized as high and very high risk and performed better than other risk models.
The model accurately predicted major adverse cardiovascular events in women who were categorized as high and very high risk and performed better than other risk models.
The FDA has granted Breakthrough Device designation to CLAiR, an AI-driven platform that uses images from routine eye exams to non-invasively assess and predict cardiovascular disease risk.
Scientists believe they found a way to detect the earliest warning signs of cardiovascular disease using a simple saliva sample.
Read MorePhysician-scientists conducted a large-scale analysis to assess the impact of a new equation used to evaluate one’s heart failure risk.
Read MoreArterial stiffness may cause premature cardiac damage in youth, but decreasing blood pressure and insulin resistance may reduce this effect by 50%
Read MoreA new American Heart Association scientific statement highlights evidence that supports shared decision-making between patients and providers, presenting models and ways to measure it in research.
Read MoreThe FDA cautions health providers to stop using the Quidel Triage Cardiac Panel due to potential inaccuracies in troponin levels. Alternatives are recommended to ensure accurate diagnoses for myocardial infarction.
Read MoreHackensack University Medical Center introduces the Coroventis CoroFlow Cardiovascular System, a groundbreaking diagnostic tool for microvascular disease. This wireless device allows accurate assessment and diagnosis of heart function, helping identify the causes of symptoms and providing effective treatment options. Learn how this innovation is transforming heart care at Hackensack.
Read MoreA recent study conducted at Wake Forest University School of Medicine highlights the value of cardiac magnetic resonance imaging in evaluating patients with chest pain and mildly elevated troponin levels.
Read MoreA retrospective analysis highlights the underutilization of preprocedure imaging in left atrial appendage occlusion (LAAO) procedures. Patients who underwent preprocedural imaging experienced slightly better device and procedural success rates.
Read MoreA systematic review and meta-analysis shed light on the prognosis of hypertrophic cardiomyopathy (HCM) based on gender differences. Female patients with HCM exhibit distinct clinical characteristics and face higher risks of adverse outcomes. These findings may guide future guidelines for sex-specific risk assessment and management strategies in HCM.
Read More